JP2019530878A5 - - Google Patents

Download PDF

Info

Publication number
JP2019530878A5
JP2019530878A5 JP2019519961A JP2019519961A JP2019530878A5 JP 2019530878 A5 JP2019530878 A5 JP 2019530878A5 JP 2019519961 A JP2019519961 A JP 2019519961A JP 2019519961 A JP2019519961 A JP 2019519961A JP 2019530878 A5 JP2019530878 A5 JP 2019530878A5
Authority
JP
Japan
Prior art keywords
patient
biomarker
days
label
c11orf74
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019519961A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019530878A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/029468 external-priority patent/WO2018004806A1/en
Publication of JP2019530878A publication Critical patent/JP2019530878A/ja
Publication of JP2019530878A5 publication Critical patent/JP2019530878A5/ja
Priority to JP2022110659A priority Critical patent/JP2022153436A/ja
Pending legal-status Critical Current

Links

JP2019519961A 2016-06-26 2017-04-25 重篤患者における死亡率の予後診断に使用するためのバイオマーカー Pending JP2019530878A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022110659A JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662354789P 2016-06-26 2016-06-26
US62/354,789 2016-06-26
PCT/US2017/029468 WO2018004806A1 (en) 2016-06-26 2017-04-25 Biomarkers for use in prognosis of mortality in critically ill patients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022110659A Division JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Publications (2)

Publication Number Publication Date
JP2019530878A JP2019530878A (ja) 2019-10-24
JP2019530878A5 true JP2019530878A5 (https=) 2020-06-11

Family

ID=60786346

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019519961A Pending JP2019530878A (ja) 2016-06-26 2017-04-25 重篤患者における死亡率の予後診断に使用するためのバイオマーカー
JP2022110659A Pending JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022110659A Pending JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Country Status (7)

Country Link
US (4) US10344332B2 (https=)
EP (1) EP3475473A4 (https=)
JP (2) JP2019530878A (https=)
CN (2) CN109451744B (https=)
AU (2) AU2017289600A1 (https=)
CA (1) CA3024724A1 (https=)
WO (1) WO2018004806A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018004806A1 (en) * 2016-06-26 2018-01-04 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for use in prognosis of mortality in critically ill patients
WO2018140256A1 (en) * 2017-01-17 2018-08-02 Duke University Gene expression signatures useful to predict or diagnose sepsis and methods of using the same
AU2019227186B2 (en) 2018-02-27 2025-07-10 The Board Of Trustees Of The Leland Stanford Junior University Classifier for identification of robust sepsis subtypes
AU2020244763A1 (en) * 2019-03-22 2021-09-30 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
JP2022530323A (ja) 2019-04-28 2022-06-29 ビスビュー メディカル,インコーポレイテッド デジタル検出能力および無線接続性を有する分子診断デバイス
EP4052042A1 (en) * 2019-10-28 2022-09-07 F. Hoffmann-La Roche AG Sepsis management
AU2021264555A1 (en) * 2020-04-29 2022-11-17 Inflammatix, Inc. Determining mortality risk of subjects with viral infections
EP4217067A4 (en) * 2020-09-25 2025-02-12 The Board Of Trustees Of The Leland Stanford Junior University Method for determining a virally-infected subject's risk of developing severe symptoms
CN114606308A (zh) * 2022-01-26 2022-06-10 江门市中心医院 脓毒症ards的预后与治疗标志物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245615A (en) 1991-06-06 1993-09-14 International Business Machines Corporation Diagnostic system and interface for a personal computer
EA001835B1 (ru) 1996-07-12 2001-08-27 Ферст Опинион Корпорейшн Автоматизированный способ диагностики (варианты)
WO2004044556A2 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
CN101208602A (zh) * 2005-04-15 2008-06-25 贝克顿迪金森公司 脓毒症的诊断
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US20090297474A1 (en) * 2005-11-25 2009-12-03 Dermot Kelleher Method for Detecting or Monitoring Sepsis by Analysing Cytokine mRNA Expression Levels
EP2388594A1 (en) * 2010-05-17 2011-11-23 Roche Diagnostics GmbH GDF-15 based means and methods for survival and recovery prediction in acute inflammation
US20110312521A1 (en) * 2010-06-17 2011-12-22 Baylor Research Institute Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
US20120034214A1 (en) * 2010-07-22 2012-02-09 Isis Innovation Limited Methods and kits for determining the prognosis of pulmonary sarcoidosis
KR20180118822A (ko) * 2011-01-11 2018-10-31 가부시키가이샤 엘에스아이 메디엔스 패혈증 예후의 예측 방법
WO2012115885A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
US20150024969A1 (en) * 2011-09-12 2015-01-22 The Children's Mercy Hospital Sepsis prognosis biomarkers
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification
EP3117030B1 (en) * 2014-03-14 2022-04-27 Hancock, Robert, E.W. Diagnostic for sepsis
WO2018004806A1 (en) * 2016-06-26 2018-01-04 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for use in prognosis of mortality in critically ill patients

Similar Documents

Publication Publication Date Title
JP2019530878A5 (https=)
TWI580788B (zh) 用於檢測川崎病的方法及套組
JP2018514189A5 (https=)
RU2014120427A (ru) Определение микрорнк в плазме для обнаружения ранних стадий колоректального рака
US20140094381A1 (en) Predictive Biomarkers for Response to Exercise
AU2019275457A1 (en) Circulating RNA signatures specific to preeclampsia
CN109295204B (zh) 诊断冠心病的外周血单个核细胞环状RNAs及相关应用
CA3166628A1 (en) Method for predicting the likelihood of ectopic pregnancy (ep), viable intrauterine pregnancy (viup), or non-viable intrauterine pregnancy (nviup).
WO2013179672A1 (ja) 子宮内膜症の判定方法
CN108026585B (zh) 多基因检测
RU2287158C1 (ru) Способ прогнозирования развития гипертонической болезни по генетическим факторам риска
El-Ahmad et al. Liquid biopsy in neuropsychiatric disorders: a step closer to precision medicine
Cazalis et al. Whole blood ratio of CDK1/CX3CR1 mRNA expression combined to lactate refines the prediction of ICU mortality in septic patients in the Sepsis-3 era: a proof-of-concept study
CN107043770B (zh) 一组结核病相关的外周血淋巴细胞miRNA及其应用
RU2620561C1 (ru) Способ диагностики псориаза
JP6612509B2 (ja) 大腸癌の予後診断を補助する方法、記録媒体および判定装置
Ju et al. Plasma cell‐free DNA analysis for COVID‐19 and beyond
Kasaras Future diagnostic of Sepsis: Biomarker miRSeps-5 manual vs robotic extraction and optimization of miRNA detection by Two-Tailed RT-qPCR technology
JP2015133919A (ja) 筋萎縮性側索硬化症のバイオマーカー
Elalawi et al. MicroRNA-377 Expression Level as a Marker of Nephropathy in Type 2 Diabetes Mellitus
CN102839173B (zh) HIV感染疾病进展分子标志物miR-200c
Razzaq et al. ESTIMATION OF IL-6 (174G> C) GENE EXPRESSION WITH CHRONIC HYPERTENSION PATIENTS IN IRAQI POPULATION.
CN107619868B (zh) 胶质瘤预后标志物Circ3:129880309|129880559的应用
TW201625796A (zh) 評估罹患大腸直腸癌風險的方法及標誌物
CN107604074B (zh) 胶质瘤预后标志物circ15:101235082|101235577及应用